Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Director dealings: BAT, Diaceutics execs make investments
(Sharecast News) - Among the list of director buys on Tuesday was British American Tobacco, after its chief executive picked up more than a quarter-of-a-million pounds worth of shares. The company said Tadeu Marroco bought 10,000 shares on 6 June, in a single transaction on the London Stock Exchange.
He paid £25.73855 for each share, valuing the transaction at £257,385.53.
The investment came after the firm held its full-year revenue and profit guidance in an update on Tuesday morning, with trading set to be weighted towards the second half.
Elsewhere, pharmaceutical technology specialist Diaceutics disclosed a purchase made by its chief financial officer.
The company said Nick Roberts bought 21,742 shares on 5 June, also in a single transaction in London.
Roberts paid 91.75p for each share, and as a result of the investment, his shareholding now totalled 62,576 shares, representing approximately 0.07% of the company's issued share capital.
At 1407 BST, shares in British American Tobbacco were up 1.15%at 2,600p, while those in Diaceutic were down 0.62% at 90.44p.
Reporting by Josh White for Sharecast.com.
Top Director Buys
London Stock Exchange Group (LSEG) Director name: Brand,Martin Amount purchased: 4,940 @ 8,553.69p Value: �422,552.30
British American Tobacco (BATS) Director name: Marroco,Tadeu Amount purchased: 10,000 @ 2,573.86p Value: �257,385.50
Neometals Ltd Npv (di) (NMT) Director name: Ritchie,Douglas Amount purchased: 70,000 @ $0.57 Value: $21,193.05
Diaceutics (DXRX) Director name: Roberts,Nick Amount purchased: 21,742 @ 91.75p Value: �19,948.29
Team (TEAM) Director name: Clubb,Jonathan Mark Gordon Amount purchased: 47,500 @ 40.95p Value: �19,451.25
Aquis Exchange (AQX) Director name: Wicker-Miurin,Fields Amount purchased: 2,450 @ 407.00p Value: �9,971.50
Quarto Group Inc. (QRT) Director name: Lau,Chuk Kin Amount purchased: 5,000 @ 172.00p Value: �8,600.00
Touchstone Exploration Inc Npv (di) (TXP) Director name: Baay,Paul R. Amount purchased: 6,313 @ $0.99 Value: $3,697.49
Top Director Sells
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
